Get the Stockscreener App
40.81
7.99%
3.02
Astrana Health Inc stock is traded at $40.81, with a volume of 539.47K.
It is up +7.99% in the last 24 hours and down -16.71% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$37.79
Open:
$37.69
24h Volume:
539.47K
Relative Volume:
0.90
Market Cap:
$2.02B
Revenue:
$3.53B
Net Income/Loss:
$30.99M
P/E Ratio:
66.53
EPS:
0.6134
Net Cash Flow:
$154.99M
1W Performance:
+14.12%
1M Performance:
-16.71%
6M Performance:
+117.31%
1Y Performance:
+38.15%
1-Day Range:
$37.69
$40.90
1-Week Range:
$34.11
$40.90
52-Week Range:
$18.08
$51.60
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
40.81 | 1.78B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
404.68 | 89.76B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
267.90 | 21.48B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.77 | 12.62B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
123.59 | 12.31B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
180.06 | 11.58B | 13.84B | 1.10B | 1.49B | 10.42 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Astrana Health Inc (ASTH) Shares Surge 8.2% -- What GF Score of 85 Tells Investors - GuruFocus
Astrana Health (NASDAQ:ASTH) Rally Puts Growth In Focus - Kalkine Media
Astrana Health (NASDAQ:ASTH) Shares Up 7.9%Still a Buy? - MarketBeat
Astrana Health Jumps 7.1% After Truist Securities Maintains Buy - AlphaStreet
Astrana Health (ASTH) Is Up 10.7% After Raising 2026 Guidance And Doubling Q2 Net IncomeHas The Bull Case Changed? - simplywall.st
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call - The Globe and Mail
Astrana Health: 81% Full-Risk And Profitable (NASDAQ:ASTH) - Seeking Alpha
Is Astrana Health Inc (ASTH) a Bargain After 8.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (NASDAQ:ASTH) Stock Price Down 5.7%What's Next? - MarketBeat
ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47 - Bitget
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Truist Securities Adjusts Price Target on Astrana Health to $55 From $47, Keeps Buy Rating - marketscreener.com
Astrana Health Inc. (ASTH) Stock Analysis: Exploring A 34.77% Potential Upside - directorstalkinterviews.com
Astrana Health Submits Q2 2026 SEC Form 10-Q Detailing Financials and Share Information - Kalkine Media
Astrana Health, Inc. Q2 2026: Revenue $972.5M, EPS $0.4— 10-Q Summary - TradingView
Astrana Health (ASTH) grows Q2 2026 revenue to $972.5M with stronger profit - Stock Titan
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Astrana Health Management, Inc., for Alleged Violations of Meal & Rest Period Requirements - PR Newswire
Results: Astrana Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Moomoo
Sei Investments Co. Raises Stake in Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health (ASTH) On Earnings And Deal Plans Is It A Buying Opportunity - Sahm
Astrana Health (NASDAQ:ASTH) Raised to Buy at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Stock Rises On Cash Flow Strength And Deleveraging - simplywall.st
Astrana Health Inc. Stock 12‑Month Price Target Raised to $50.5, Implies 48% Upside - TradingView
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53 - Moomoo
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts By Investing.com - Investing.com Nigeria
Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress - Yahoo Finance
Enterprise value to revenue forward of Astrana Health Inc. – FWB:3AM - TradingView
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook - The Globe and Mail
Astrana Health beats EPS estimates, raises EBITDA guidance By Investing.com - Investing.com Nigeria
Astrana Health, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Astrana Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ASTH) 2026-08-06 - Seeking Alpha
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts - Investing.com
Astrana Health Q2 Earnings Call Highlights - MarketBeat
ASTH Looks 59.4% Undervalued on GF Value™ - GuruFocus
Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates - Yahoo Finance
ASTRANA HEALTH ($ASTH) Releases Q2 2026 Earnings - quiverquant.com
Earnings Flash (ASTH) Astrana Health, Inc. Posts Q2 Adjusted EPS $0.80 per Share, vs. FactSet Est of $0.79 - marketscreener.com
Earnings Flash (ASTH) Astrana Health, Inc. Reports Q2 Revenue $972.5M, vs. FactSet Est of $985.6M - marketscreener.com
(ASTH) Astrana Health, Inc. Expects Q3 Revenue Range $1.00B$1.03B - marketscreener.com
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1% - Barchart.com
Astrana Health, Inc. Reports Second Quarter 2026 Results - PR Newswire
Astrana Health earnings on deck after Q1 blowout results By Investing.com - Investing.com Canada
Astrana Health Q2 2026 slides: full-risk shift drives margin gains - Investing.com Canada
Astrana Health Inc. (ASTH) Stock Forecasts - Yahoo Finance
Astrana Health Inc. Stock 12‑Month Price Target Raised to $48.75, Implies 37% Upside - TradingView
Dimensional Fund Advisors LP Boosts Stake in Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health (ASTH) Q2 Earnings: What To Expect - Barchart.com
Astrana Health Inc. (ASTH) Stock Analysis: Poised For Growth With 37% Upside Potential - directorstalkinterviews.com
A Look at Astrana Health Inc (ASTH) After 3.0% Decline -- GF Val - GuruFocus
Vanguard Portfolio Management (ASTH) discloses 2.65M-share stake in Astrana Health - Stock Titan
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):